Lim, Elfamela S.
HRN: 21-74-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
CEFUROXIME 1.5GM (VIAL)
08/03/2022
08/04/2022
IVT
1.5g
Q8
S/P Curettage
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes